메뉴 건너뛰기




Volumn 20, Issue 7, 2013, Pages 708-714

Japan cancer of the prostate risk assessment for combined androgen blockade including bicalutamide: Clinical application and validation

Author keywords

Combined androgen blockade; Outcome prediction; Prostate cancer

Indexed keywords

BICALUTAMIDE; GONADORELIN AGONIST; GOSERELIN; LEUPRORELIN; LUPRIN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

EID: 84880326462     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12037     Document Type: Article
Times cited : (14)

References (23)
  • 2
    • 44949119412 scopus 로고    scopus 로고
    • Recent trends in prostate cancer mortality show a continuous decrease in several countries
    • Bouchardy C, Fioretta G, Rapiti E etal. Recent trends in prostate cancer mortality show a continuous decrease in several countries. Int. J. Cancer 2008; 123: 421-429.
    • (2008) Int. J. Cancer , vol.123 , pp. 421-429
    • Bouchardy, C.1    Fioretta, G.2    Rapiti, E.3
  • 3
    • 0242692717 scopus 로고    scopus 로고
    • Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE)
    • CaPSURE.
    • Cooperberg MR, Lubeck DP, Mehta SS, Caroll PR, CaPSURE. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J. Urol. 2003; 170: S21-25.
    • (2003) J. Urol. , vol.170
    • Cooperberg, M.R.1    Lubeck, D.P.2    Mehta, S.S.3    Caroll, P.R.4
  • 5
    • 14744299390 scopus 로고    scopus 로고
    • Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association
    • Cancer Registration Committee of the Japanese Urological Association.
    • Cancer Registration Committee of the Japanese Urological Association. Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association. Int. J. Urol. 2005; 12: 46-61.
    • (2005) Int. J. Urol. , vol.12 , pp. 46-61
  • 6
    • 6044231016 scopus 로고    scopus 로고
    • Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance
    • Akaza H, Usami M, Hinotsu S etal. Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance. Jpn. J. Clin. Oncol. 2004; 34: 329-336.
    • (2004) Jpn. J. Clin. Oncol. , vol.34 , pp. 329-336
    • Akaza, H.1    Usami, M.2    Hinotsu, S.3
  • 7
    • 41149163722 scopus 로고    scopus 로고
    • Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer
    • Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann. Intern. Med. 2008; 148: 435-448.
    • (2008) Ann. Intern. Med. , vol.148 , pp. 435-448
    • Wilt, T.J.1    MacDonald, R.2    Rutks, I.3    Shamliyan, T.A.4    Taylor, B.C.5    Kane, R.L.6
  • 8
    • 70349320376 scopus 로고    scopus 로고
    • Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy
    • Cooperberg MR, Hinotsu S, Namiki M etal. Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy. J. Clin. Oncol. 2009; 27: 4306-4313.
    • (2009) J. Clin. Oncol. , vol.27 , pp. 4306-4313
    • Cooperberg, M.R.1    Hinotsu, S.2    Namiki, M.3
  • 9
    • 68149098902 scopus 로고    scopus 로고
    • Combined androgen blockade with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival
    • Akaza H, Hinotsu S, Usami M etal. Combined androgen blockade with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival. Cancer 2009; 115: 3437-3445.
    • (2009) Cancer , vol.115 , pp. 3437-3445
    • Akaza, H.1    Hinotsu, S.2    Usami, M.3
  • 10
    • 34250008691 scopus 로고    scopus 로고
    • Bicalutamide 80mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase 3 randomized, double-blind, multicenter trial in Japanese patients
    • Usami M, Akaza H, Arai Y etal. Bicalutamide 80mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase 3 randomized, double-blind, multicenter trial in Japanese patients. Prostate Cancer Prostatic Dis. 2007; 10: 194-201.
    • (2007) Prostate Cancer Prostatic Dis. , vol.10 , pp. 194-201
    • Usami, M.1    Akaza, H.2    Arai, Y.3
  • 11
    • 78650188152 scopus 로고    scopus 로고
    • Combined androgen blockade for prostate cancer: review of efficacy, safety and cost-effectiveness
    • Akaza H. Combined androgen blockade for prostate cancer: review of efficacy, safety and cost-effectiveness. Cancer Sci. 2011; 102: 51-56.
    • (2011) Cancer Sci. , vol.102 , pp. 51-56
    • Akaza, H.1
  • 12
    • 0002387316 scopus 로고    scopus 로고
    • Prostate
    • International Union Against Cancer: Urologic Tumors. Sobin LH, Wittekind CH (eds)., 5th edn. John Wiley & Sons, New York
    • International Union Against Cancer: Urologic Tumors. Prostate. In: Sobin LH, Wittekind CH (eds). TNM Classification of Malignant Tumours, 5th edn. John Wiley & Sons, New York, 1997; 170-173.
    • (1997) TNM Classification of Malignant Tumours , pp. 170-173
  • 13
    • 24144493035 scopus 로고    scopus 로고
    • The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostate carcinoma
    • ISUP Grading Committee.
    • Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL, ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostate carcinoma. Am. J. Surg. Pathol. 2005; 29: 1228-1242.
    • (2005) Am. J. Surg. Pathol. , vol.29 , pp. 1228-1242
    • Epstein, J.I.1    Allsbrook Jr, W.C.2    Amin, M.B.3    Egevad, L.L.4
  • 14
    • 0030069896 scopus 로고    scopus 로고
    • Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
    • Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 1996; 15: 361-387.
    • (1996) Stat. Med. , vol.15 , pp. 361-387
    • Harrell Jr, F.E.1    Lee, K.L.2    Mark, D.B.3
  • 15
    • 0015370976 scopus 로고
    • Studies on prostate cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate
    • Huggins C, Hodges C. Studies on prostate cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J. Clin. 1972; 22: 232-240.
    • (1972) CA Cancer J. Clin. , vol.22 , pp. 232-240
    • Huggins, C.1    Hodges, C.2
  • 16
    • 0036290334 scopus 로고    scopus 로고
    • Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer?
    • Labrie F, Candas B, Gomez JL, Cusan L. Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer? Urology 2002; 60: 115-119.
    • (2002) Urology , vol.60 , pp. 115-119
    • Labrie, F.1    Candas, B.2    Gomez, J.L.3    Cusan, L.4
  • 17
    • 0035915453 scopus 로고    scopus 로고
    • Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study
    • Harlan LC, Potosky A, Gilliland FD etal. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J. Natl. Cancer Inst. 2001; 93: 1864-1871.
    • (2001) J. Natl. Cancer Inst. , vol.93 , pp. 1864-1871
    • Harlan, L.C.1    Potosky, A.2    Gilliland, F.D.3
  • 18
    • 33746880261 scopus 로고    scopus 로고
    • Efficacy of primary hormonal therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up
    • Akaza H, Homma Y, Usami M etal. Efficacy of primary hormonal therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up. BJU Int. 2006; 98: 573-579.
    • (2006) BJU Int. , vol.98 , pp. 573-579
    • Akaza, H.1    Homma, Y.2    Usami, M.3
  • 19
    • 24044444279 scopus 로고    scopus 로고
    • Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer
    • Janoff DM, Peterson C, Mongoue-Tchokote S etal. Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer. BJU Int. 2005; 96: 503-507.
    • (2005) BJU Int. , vol.96 , pp. 503-507
    • Janoff, D.M.1    Peterson, C.2    Mongoue-Tchokote, S.3
  • 20
    • 67349131277 scopus 로고    scopus 로고
    • Prostate specific antigen half-time and prostate specific antigen doubling time as predictors of response to androgen deprivation therapy for metastatic prostate cancer
    • Park YH, Hwang IS, Jeong CW, Kim HH, Lee SE, Kwak C. Prostate specific antigen half-time and prostate specific antigen doubling time as predictors of response to androgen deprivation therapy for metastatic prostate cancer. J. Urol. 2009; 181: 2520-2524.
    • (2009) J. Urol. , vol.181 , pp. 2520-2524
    • Park, Y.H.1    Hwang, I.S.2    Jeong, C.W.3    Kim, H.H.4    Lee, S.E.5    Kwak, C.6
  • 21
    • 0034728828 scopus 로고    scopus 로고
    • Maximum androgen blockade in advanced prostate cancer: and overview of the randomized trials
    • Prostate Cancer Trialists' Collaborative Group
    • Prostate Cancer Trialists' Collaborative Group. Maximum androgen blockade in advanced prostate cancer: and overview of the randomized trials. Lancet 2000; 355: 1491-1498.
    • (2000) Lancet , vol.355 , pp. 1491-1498
  • 22
    • 34248169161 scopus 로고    scopus 로고
    • Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline
    • Loblaw DA, Virgo KS, Nam R etal. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J. Clin. Oncol. 2007; 25: 1596-1605.
    • (2007) J. Clin. Oncol. , vol.25 , pp. 1596-1605
    • Loblaw, D.A.1    Virgo, K.S.2    Nam, R.3
  • 23
    • 84857946027 scopus 로고    scopus 로고
    • Fifth Joint Meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its management
    • Akaza H, Carroll P, Cooperberg MR, Hinotsu S. Fifth Joint Meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its management. Jpn. J. Clin. Oncol. 2012; 42: 226-236.
    • (2012) Jpn. J. Clin. Oncol. , vol.42 , pp. 226-236
    • Akaza, H.1    Carroll, P.2    Cooperberg, M.R.3    Hinotsu, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.